- Search term must have more than 2 characters.
For traditional medicinal products and devices, the steps of the innovation pathway in EU member states are relatively clear and well-defined. However, in recent years there has been rapid growth in a new sector: medical and health technology products, such as software or digital diagnostic tools. An important part is played specifically by digital health products and services.
Innovators and other stakeholders developing digital health and telemedicine products can often face difficulties in achieving widespread adoption, due to local procurement barriers or other infrastructural challenges. Such barriers can delay potentially impactful solutions from reaching patients and citizens.
The current COVID-19 pandemic substantially eliminated resistance to digital innovations and accelerated the need for health services available from home, including telemedicine.
So what is the future of digital health and telemedicine in the world and in the Czech Republic? And how can these innovations impact health economics and adoption of these innovations among stakeholders? Come and join our discussion!
11:30 Networking and individual follow-ups
Priit is the CEO of Dermtest, Estonia, with 10 years of experience in healthcare analytics, health policy research, digital health consulting and team management in public, non-governmental and private sector.
He is the co-author of high-impact policy papers, including national telemedicine and personalized medicine implementation plans and long-term solvency model for national health insurance, as well as acts as the member of the advisory board at Estonian Connected Health cluster and lecturer at digital health technologies MSc study program at TalTech.
Yoav is the Head of technological Innovation and digital health at HealthIL, based in Israel.
He focuses on the business/financial strategy of startups and venture capital. Yoav is an expert in the field of digital health and healthcare Innovation, helping health organizations and corporate healthcare stakeholders to define and prioritize their needs and challenges, matching to Israeli startups.
Lenka Lhotská is the associated professor at Czech Technical University in Prague, she focuses on Artifical Intelligence, Machine learning, Algorithms and many more.
This event is not open to the public and participants are confirmed based on personal invitation. In case you were not invited yet, but would like to participate, please send email to firstname.lastname@example.org with a short link/bio of yourself and the reason how could you contribute to the event and why it is interesting for you.